Talk Highlights:

  • Research on platelet-based therapy is showing promising results for Long COVID patients
  • Gut health and microbiome function are essential foundations for chronic illness recovery
  • Data-driven dosing strategies and hormetic responses optimize treatment protocols for better outcomes
VIEW TRANSCRIPT
LISTEN TO AUDIO
back to schedule

Day 2 Curated Lineup

Galectin-3 in Long COVID: Biomarker to Treatment (21 min)
Ruby Tischoff, FDN-P
Long COVID: A Neurological Health Crisis (53 min)
Suzanne Gazda, MD
Energy Recovery Through Optimizing Circadian Biology (55 min)
Eleanor Stein, MD, FRCP(C)
The Intersection of Platelet Therapy and Chronic Illness Recovery (35 min)
Tapley Holland
T Cell Dynamics and Testing in Long COVID and ME/CFS [PRO LEVEL] (35 min)
Felix Scholz, PhD
Spike Protein Detoxification and Recovery Solutions (43 min)
Fabio Zoffi
Chiropractic Neurology Approach to Long COVID Recovery (38 min)
Joe Smith, DC

Day 2 - Bonus Content

Plasmapheresis: Blood Filtration Reducing Inflammation and Toxins (10 min)
Eric Gordon, MD
Loss of Immune Tolerance in Long COVID (48 min)
Jamie Kunkle, ND
Workshop: Why Your Fascia Health Matters (87 min)
Deanna Hansen
RETURN TO SCHEDULE

About the Expert

Tapley Holland

Website

Tapley Holland is the creator of the TruDOSE™ Technology, a patented intelligent software testing platform that solved the longstanding dosing inaccuracy problem within the field of regenerative medicine. This technology led to uncovering the healing benefits of infusing dose specific platelets back into the bloodstream, otherwise known as TruDOSE™ IV platelet therapy. Since 2018, the TruDOSE technology and IV therapy has treated, and reversed, thousands of patients with unsolvable symptoms and disease conditions.

Gain Access to Exclusive Offers From Our Sponsors

Leela Quantum Tech ecoNugenics TruDose
Scroll to Top